I

Incyte

Biopharmaceutical company pursuing drug discovery.

Director, Medical Affairs - Dermatology

Biology & BiotechUpdated on Nov 10
Full-timeRemote in CanadaNo salary listed

About the Job

Requirements

  • At least 10 years of pharmaceutical industry experience in Medical Affairs or related roles, including at least five to seven years in dermatology, inflammation, and/or autoimmune diseases.
  • A strong understanding of the Canadian healthcare and reimbursement landscape.
  • Proven leadership and people-management experience.
  • The ability to turn complex scientific information into clear priorities and effective action.
  • An entrepreneurial mindset, strong business acumen, and the judgment to navigate a broad, evolving remit.
  • A record of bringing fresh ideas, challenging assumptions constructively, and building productive partnerships.
  • Excellent written and verbal communication skills.
  • Proficiency in Microsoft Outlook, Word, Excel, and PowerPoint.
  • The ability to travel up to 50% of working time.

Responsibilities

  • Develop and execute strategic medical plans that reflect Canadian clinical needs, emerging science, and portfolio opportunities.
  • Build sustained relationships and conduct meaningful scientific exchanges with healthcare professionals, researchers, and clinical experts.
  • Lead company-sponsored and investigator-sponsored studies with relevant teams to address evidence gaps.
  • Support marketed medicines and pipeline assets through medical education, evidence generation, and cross-functional planning.
  • Provide guidance to MSL colleagues and, where applicable, lead and develop the team.
  • Build and maintain expertise in assigned therapeutic areas, including disease landscapes, treatment options, company medicines and pipeline assets, reimbursement environments, and emerging research.
  • Translate therapeutic-area knowledge into medical priorities, actionable plans, and professional and patient-centered initiatives.
  • Contribute the medical perspective to cross-functional brand planning while maintaining scientific integrity and the independence of medical decision-making.
  • Provide medical leadership for training and educational initiatives.
  • Contribute scientific and clinical expertise to Market Access submissions and value dossiers.
  • Lead medical and scientific exchanges with healthcare professionals, researchers, and clinical experts.
  • Develop medical education programs and scientific communication materials that address relevant knowledge gaps.
  • Oversee medical congress planning and related scientific communication activities.
  • Lead advisory boards, investigator meetings, and other scientific engagement activities.
  • Lead the medical review of promotional and non-promotional materials.
  • Ensure unsolicited medical information requests about company medicines and pipeline assets are appropriately answered and documented.
  • Lead company-sponsored and investigator-sponsored studies in collaboration with relevant local and global teams.
  • Support local Special Access Programs.
  • Partner closely with Clinical Development, Global Medical Affairs, Regulatory Affairs, Market Access, Marketing, and Sales.
  • Bring insights from Canadian clinical practice into organizational discussions and decisions.
  • Model company values and ensure activities meet applicable regulatory, legal, and company requirements.

Desired Qualifications

  • An MD, PharmD, or PhD in a life sciences discipline is preferred.
  • Fluency in English and French is strongly preferred.

About the Company

Incyte

Biopharmaceutical company pursuing drug discovery.

Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Wilmington, DE
Founded
1991

Recently Posted Jobs

Explore more opportunities at Incyte

See more jobs